HCPLive

NOVEMBER 24, 2024

New 52-week LUNA and 4-year OPTIC data demonstrate Ixo-vec’s potential to reduce injection burden, maintain vision, and achieve lifelong benefits for wet AMD.

96

96

CardiacWire

NOVEMBER 24, 2024

Impressive results from the Phase 2 KRAKEN trial presented at the AHA 2024 Scientific Sessions showed that Eli Lilly’s muvalaplin greatly reduces Lp(a) blood levels, adding an attractive oral option to its Lp(a) pipeline. High Lp(a) is an inherited CVD risk factor that impacts one out of every five people and currently has no approved drug therapies.

Risk Factors 59

Risk Factors Outcomes Cholesterol 59

Frontiers in Cardiovascular Medicine

NOVEMBER 24, 2024

ObjectiveTo study the changes in gastrointestinal wall thickness, blood flow, motility, and symptoms in patients with acute heart failure, and to assess gastrointestinal function by ultrasound.MethodsIn this study, patients diagnosed with acute heart failure were selected as the study group, and healthy individuals were selected as the control group.

Heart Failure 52

Heart Failure Ultrasound Research 52

HCPLive

NOVEMBER 24, 2024

Arnold discussed his research in analyzing and improving current classifications of ANA-RMDs and how it could help improve research in the field.

Research 52

Research 52

Frontiers in Cardiovascular Medicine

NOVEMBER 24, 2024

BackgroundHierarchical management of sports risk is highly critical to ensure the safety of sports rehabilitation. Early identification, timely prevention and control of sports-related risk factors, and enhanced supervision and guidance can provide a basis for the formulation of sports programmes and the setting of sports monitoring levels.ObjectiveThis study aimed to retrieve, evaluate, and integrate evidence for the stratified management of motor risk in patients with a cardiac implantable ele

Exercise 52

Exercise Best Practices Nursing Risk Factors 52

The American Journal of Cardiology

NOVEMBER 24, 2024

Publication date: Available online 24 November 2024 Source: The American Journal of Cardiology Author(s): Abdullah Al-Abcha, Shannon Clay, Ling Wang, Rohan Madhu Prasad, Mohammad Fahad Salam, Shaurya Srivastava, Manel Boumegouas, George S Abela, Yehia Saleh, Essa M Essa

40

40

Frontiers in Cardiovascular Medicine

NOVEMBER 24, 2024

ObjectiveTo investigate the correlation between remnant cholesterol (RC) and premature coronary artery disease (PCAD) and the severity of coronary artery lesions in men.MethodsA total of 630 male subjects who underwent coronary angiography were included in the study. The general data, laboratory tests, and coronary angiography data of each group were statistically analyzed, and RC levels were calculated.

Coronary Artery Disease 52

Coronary Artery Disease Cholesterol Risk Factors Laboratory 52

Frontiers in Cardiovascular Medicine

NOVEMBER 24, 2024

BackgroundObservational studies have shown an association between Breast Cancer (BC) and Atrial Fibrillation (AF). However, due to confounding factors and reverse causality, the causal role between BC and AF remains unclear. In this study, bidirectional two-sample Mendelian randomization (MR) combined with meta-analysis was used to evaluate the causal association between BC and AF.MethodsBased on the Genome-Wide Association Studies (GWAS) summary data sets, the Inverse variance weighted (IVW) me

Atrial Fibrillation 52

Atrial Fibrillation Cancer Research 52

Circulation

NOVEMBER 24, 2024

Circulation, Volume 150, Issue 22 , Page e467-e467, November 26, 2024.

Article 45

Article Pulmonary Hypertension Circulation 45

Frontiers in Cardiovascular Medicine

NOVEMBER 24, 2024

Spontaneous coronary artery dissection (SCAD) is a relevant non-atherosclerotic cause of acute coronary syndrome with a complex genetic architecture. Recent discoveries have highlighted the potential role of miRNAs and protein-coding genes involved in the processing of small RNAs in the pathogenesis of SCAD. Furthermore, there may be a connection between SCAD and the increased cardiovascular risk observed in fragile X premutation carriers as well as a correlation with pathogenetic variants in ge

SCAD 52

SCAD 52

Circulation

NOVEMBER 24, 2024

Circulation, Volume 150, Issue 22 , Page 1745-1746, November 26, 2024.

Electrophysiology 45

Electrophysiology Technology Circulation 45

Frontiers in Cardiovascular Medicine

NOVEMBER 24, 2024

IntroductionHeart failure (HF) burdens the US healthcare system, with annual costs exceeding $30 billion. Outpatient intravenous (OP IV) diuresis in clinic or home settings may potentially improve outcomes and reduce costs, though limited data exists. This systematic review evaluates the safety, efficacy, and outcomes of OP IV diuresis in managing decompensated HF as a hospitalization alternative.MethodsFollowing PRISMA 2020 guidelines, this systematic review used MeSH terms in MEDLINE, SCOPUS,

Outpatient 52

Outpatient Heart Failure Medicare Inpatient 52

Stroke Journal

NOVEMBER 24, 2024

Stroke, Volume 55, Issue 12 , Page e330-e331, December 1, 2024.

Strokes 40

Strokes Stroke 40

Frontiers in Cardiovascular Medicine

NOVEMBER 24, 2024

BackgroundIn medical practice, atrial fibrillation (AF) is intricately associated with heart failure (HF). Currently, ethanol infusion of vein of Marshall (EIVOM) for AF ablation in HF patients remains significantly limited.MethodThis was a non-randomized, single-center, retrospective observational study. AF patients received 4-step ablation composed of EIVOM, pulmonary vein isolation (PVI) and linear ablation.

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure Ablation Pulmonary 52

Stroke Journal

NOVEMBER 24, 2024

Stroke, Volume 55, Issue 12 , Page 2773-2773, December 1, 2024.

Strokes 40

Strokes Stroke 40

Stroke Journal

NOVEMBER 24, 2024

Stroke, Volume 55, Issue 12 , Page e439-e439, December 1, 2024.

Strokes 40

Strokes Stroke 40